-
公开(公告)号:US07732492B2
公开(公告)日:2010-06-08
申请号:US11349225
申请日:2006-02-08
申请人: Chisato Makino , Erika Motomura , Kunikazu Suzuki , Takahiko Andou , Nobutaka Ninomiya , Akira Yabuki
发明人: Chisato Makino , Erika Motomura , Kunikazu Suzuki , Takahiko Andou , Nobutaka Ninomiya , Akira Yabuki
CPC分类号: A61K31/198 , A61K9/2027 , A61K9/2054
摘要: The present invention provides a small-sized preparation that is easy to take, containing 26% or more of nateglinide and 28% or more of at least one disintegrant selected from the group consisting of carmellose or salts thereof, sodium carboxymethyl starch, croscarmellose sodium, crospovidone, partly pregelatinized starch and low-substituted hydroxypropyl cellulose, based on the total mass of the preparation. The preparation of the present invention has high contents of nateglinide, which can be absorbed immediately to exhibit a hypoglycemic action.
摘要翻译: 本发明提供一种容易服用的小型制剂,其含有所述那格列奈26%或更多,选自羧甲基纤维素或其盐的至少一种崩解剂的28%或更多,羧甲基淀粉钠,交联羧甲基纤维素钠, 交联聚维酮,部分预胶化淀粉和低取代羟丙基纤维素,基于制剂的总质量。 本发明的制剂具有高的那格列奈含量,其可立即被吸收以显示降血糖作用。
-
公开(公告)号:US20060127475A1
公开(公告)日:2006-06-15
申请号:US11349225
申请日:2006-02-08
申请人: Chisato Makino , Erika Motomura , Kunikazu Suzuki , Takahiko Andou , Nobutaka Ninomiya , Akira Yabuki
发明人: Chisato Makino , Erika Motomura , Kunikazu Suzuki , Takahiko Andou , Nobutaka Ninomiya , Akira Yabuki
IPC分类号: A61K9/20 , A61K31/195
CPC分类号: A61K31/198 , A61K9/2027 , A61K9/2054
摘要: The present invention provides a small-sized preparation that is easy to take, containing 26% or more of nateglinide and 28% or more of at least one disintegrant selected from the group consisting of carmellose or salts thereof, sodium carboxymethyl starch, croscarmellose sodium, crospovidone, partly pregelatinized starch and low-substituted hydroxypropyl cellulose, based on the total mass of the preparation. The preparation of the present invention has high contents of nateglinide, which can be absorbed immediately to exhibit a hypoglycemic action.
摘要翻译: 本发明提供一种容易服用的小型制剂,其含有所述那格列奈26%或更多,选自羧甲基纤维素或其盐的至少一种崩解剂的28%或更多,羧甲基淀粉钠,交联羧甲基纤维素钠, 交联聚维酮,部分预胶化淀粉和低取代羟丙基纤维素,基于制剂的总质量。 本发明的制剂具有高的那格列奈含量,其可立即被吸收以显示降血糖作用。
-
公开(公告)号:US07488498B2
公开(公告)日:2009-02-10
申请号:US11246453
申请日:2005-10-11
申请人: Chisato Makino , Nobutaka Ninomiya , Haruo Orita , Hidetoshi Sakai , Akira Yabuki , Nobuo Kato , Shigeru Shioya
发明人: Chisato Makino , Nobutaka Ninomiya , Haruo Orita , Hidetoshi Sakai , Akira Yabuki , Nobuo Kato , Shigeru Shioya
CPC分类号: A61K9/0095 , A61K9/146 , A61K9/1617 , A61K9/1647 , A61K9/1652 , A61K9/2054 , A61K9/209 , A61K9/2853 , A61K9/2866 , A61K9/5026 , A61K9/5031 , A61K9/5036 , A61K9/5084 , A61K31/195 , A61K31/198 , A61K45/06 , A61K2300/00
摘要: There is provided a single preparation which directly decreases both of the post prandial blood glucose level and the fasting blood glucose level close to normal levels, by release-sustaining a drug capable of decreasing the post prandial blood glucose level of diabetic patients close to the normal level, or mixing a controlled release drug capable of decreasing the post prandial blood glucose level close to the normal level with an immediate release drug. It is particularly preferable that the drug capable of decreasing the post prandial blood glucose level close to the normal level is nateglinide.
摘要翻译: 提供了一种直接降低餐后血糖水平和接近正常水平的空腹血糖水平的单一制剂,通过释放维持能够降低接近正常的糖尿病患者的餐后血糖水平的药物 或者使用立即释放药物混合能够降低接近正常水平的餐后血糖水平的控释药物。 特别优选能够降低接近正常水平的餐后血糖水平的药物是那格列奈。
-
公开(公告)号:US20060029669A1
公开(公告)日:2006-02-09
申请号:US11246453
申请日:2005-10-11
申请人: Chisato Makino , Nobutaka Ninomiya , Haruo Orita , Hidetoshi Sakai , Akira Yabuki , Nobuo Kato , Shigeru Shioya
发明人: Chisato Makino , Nobutaka Ninomiya , Haruo Orita , Hidetoshi Sakai , Akira Yabuki , Nobuo Kato , Shigeru Shioya
IPC分类号: A61K9/22
CPC分类号: A61K9/0095 , A61K9/146 , A61K9/1617 , A61K9/1647 , A61K9/1652 , A61K9/2054 , A61K9/209 , A61K9/2853 , A61K9/2866 , A61K9/5026 , A61K9/5031 , A61K9/5036 , A61K9/5084 , A61K31/195 , A61K31/198 , A61K45/06 , A61K2300/00
摘要: There is provided a single preparation which directly decreases both of the post prandial blood glucose level and the fasting blood glucose level close to normal levels, by release-sustaining a drug capable of decreasing the post prandial blood glucose level of diabetic patients close to the normal level, or mixing a controlled release drug capable of decreasing the post prandial blood glucose level close to the normal level with an immediate release drug. It is particularly preferable that the drug capable of decreasing the post prandial blood glucose level close to the normal level is nateglinide.
-
公开(公告)号:US07605180B2
公开(公告)日:2009-10-20
申请号:US10421898
申请日:2003-04-24
申请人: Nobutaka Ninomiya , Chisato Makino , Akira Yabuki
发明人: Nobutaka Ninomiya , Chisato Makino , Akira Yabuki
IPC分类号: A61K31/195 , C07C229/00
CPC分类号: A61K31/192 , A61K31/198
摘要: The present invention discloses, as a immediate-release preparation useful as an antidiabetic, a nateglinide-containing preparation comprising nateglinide as an active ingredient wherein the nateglinide is amorphous.
摘要翻译: 本发明公开了作为抗糖尿病药物的即时释放制剂,其包含那格列奈作为活性成分的那格列奈制剂,其中那格列奈是无定形的。
-
公开(公告)号:US20090203791A1
公开(公告)日:2009-08-13
申请号:US12424958
申请日:2009-04-16
申请人: Nobutaka NINOMIYA , Chisato Makino , Akira Yabuki
发明人: Nobutaka NINOMIYA , Chisato Makino , Akira Yabuki
IPC分类号: A61K31/195 , A61P3/10
CPC分类号: A61K31/192 , A61K31/198
摘要: The present invention discloses, as a immediate-release preparation useful as an antidiabetic, a nateglinide-containing preparation comprising nateglinide as an active ingredient wherein the nateglinide is amorphous.
摘要翻译: 本发明公开了作为抗糖尿病药物的即时释放制剂,其包含那格列奈作为活性成分的那格列奈制剂,其中那格列奈是无定形的。
-
公开(公告)号:US07022339B2
公开(公告)日:2006-04-04
申请号:US10183322
申请日:2002-06-28
申请人: Chisato Makino , Nobutaka Ninomiya , Haruo Orita , Hidetoshi Sakai , Akira Yabuki , Nobuo Kato , Shigeru Shioya
发明人: Chisato Makino , Nobutaka Ninomiya , Haruo Orita , Hidetoshi Sakai , Akira Yabuki , Nobuo Kato , Shigeru Shioya
CPC分类号: A61K9/0095 , A61K9/146 , A61K9/1617 , A61K9/1647 , A61K9/1652 , A61K9/2054 , A61K9/209 , A61K9/2853 , A61K9/2866 , A61K9/5026 , A61K9/5031 , A61K9/5036 , A61K9/5084 , A61K31/195 , A61K31/198 , A61K45/06 , A61K2300/00
摘要: There is provided a single preparation which directly decreases both of the post prandial blood glucose level and the fasting blood glucose level close to normal levels, by release-sustaining a drug capable of decreasing the post prandial blood glucose level of diabetic patients close to the normal level, or mixing a controlled release drug capable of decreasing the post prandial blood glucose level close to the normal level with an immediate release drug. It is particularly preferable that the drug capable of decreasing the post prandial blood glucose level close to the normal level is nateglinide.
-
公开(公告)号:US06830759B2
公开(公告)日:2004-12-14
申请号:US10183405
申请日:2002-06-28
申请人: Chisato Makino , Nobutaka Ninomiya , Haruo Orita , Hidetoshi Sakai , Akira Yabuki , Nobuo Kato , Shigeru Shioya
发明人: Chisato Makino , Nobutaka Ninomiya , Haruo Orita , Hidetoshi Sakai , Akira Yabuki , Nobuo Kato , Shigeru Shioya
IPC分类号: A61K920
CPC分类号: A61K31/00 , A61K9/2077 , A61K9/2081 , A61K31/195 , A61K45/06
摘要: There is provided a single preparation which directly decreases both of the post prandial blood glucose level and the fasting blood glucose level close to normal levels, by release-sustaining a drug capable of decreasing the post prandial blood glucose level of diabetic patients close to the normal level, or mixing a controlled release drug capable of decreasing the post prandial blood glucose level close to the normal level with an immediate release drug. It is particularly preferable that the drug capable of decreasing the post prandial blood glucose level close to the normal level is nateglinide, repaglinide, or mitiglinide (KAD-1229).
摘要翻译: 提供了一种直接降低餐后血糖水平和接近正常水平的空腹血糖水平的单一制剂,通过释放维持能够降低接近正常的糖尿病患者的餐后血糖水平的药物 或者使用立即释放药物混合能够降低接近正常水平的餐后血糖水平的控释药物。 特别优选能够降低接近正常水平的餐后血糖水平的药物是那格列奈,瑞格列奈或米格列奈(KAD-1229)。
-
公开(公告)号:US07138142B2
公开(公告)日:2006-11-21
申请号:US10897000
申请日:2004-07-23
申请人: Hidetoshi Sakai , Mitsuyasu Ida , Chisato Makino , Tomoaki Kawano , Akira Yabuki
发明人: Hidetoshi Sakai , Mitsuyasu Ida , Chisato Makino , Tomoaki Kawano , Akira Yabuki
CPC分类号: A61K9/0095 , A61K9/1617 , A61K9/1635 , A61K31/198
摘要: The problem of the present invention is to provide pharmaceutical granules containing, as active amino acid ingredients, three kinds of branched chain amino acids of isoleucine, leucine and valine, which has a smaller specific volume than conventional products, and a production method thereof. As a result of intensive studies, granules containing, as active amino acid ingredients, three kinds of branched chain amino acids of isoleucine, leucine and valine and a production method thereof have been provided, which are characterized by adding an acid to a particle mixture of three kinds of branched chain amino acids of isoleucine, leucine and valine and granulating the mixture, which has solved the above-mentioned problem.
摘要翻译: 本发明的问题是提供含有作为活性氨基酸成分的异氰酸,亮氨酸,缬氨酸三种支链氨基酸的药物颗粒,其具有比常规产品更小的比容量及其制备方法。 作为深入研究的结果,提供了含有作为活性氨基酸成分的异亮氨酸,亮氨酸和缬氨酸的三种支链氨基酸的颗粒及其制备方法,其特征在于将酸添加到 3种异亮氨酸,亮氨酸,缬氨酸的支链氨基酸,混合造粒,解决了上述问题。
-
公开(公告)号:US20050003015A1
公开(公告)日:2005-01-06
申请号:US10897000
申请日:2004-07-23
申请人: Hidetoshi Sakai , Mitsuyasu Ida , Chisato Makino , Tomoaki Kawano , Akira Yabuki
发明人: Hidetoshi Sakai , Mitsuyasu Ida , Chisato Makino , Tomoaki Kawano , Akira Yabuki
CPC分类号: A61K9/0095 , A61K9/1617 , A61K9/1635 , A61K31/198
摘要: The problem of the present invention is to provide pharmaceutical granules containing, as active amino acid ingredients, three kinds of branched chain amino acids of isoleucine, leucine and valine, which has a smaller specific volume than conventional products, and a production method thereof. As a result of intensive studies, granules containing, as active amino acid ingredients, three kinds of branched chain amino acids of isoleucine, leucine and valine and a production method thereof have been provided, which are characterized by adding an acid to a particle mixture of three kinds of branched chain amino acids of isoleucine, leucine and valine and granulating the mixture, which has solved the above-mentioned problem.
摘要翻译: 本发明的问题是提供含有作为活性氨基酸成分的异氰酸,亮氨酸,缬氨酸三种支链氨基酸的药物颗粒,其具有比常规产品更小的比容量及其制备方法。 作为深入研究的结果,提供了含有作为活性氨基酸成分的异亮氨酸,亮氨酸和缬氨酸的三种支链氨基酸的颗粒及其制备方法,其特征在于将酸添加到 3种异亮氨酸,亮氨酸,缬氨酸的支链氨基酸,混合造粒,解决了上述问题。
-
-
-
-
-
-
-
-
-